HealthForbes Business
The GLP-1 Shortage Is Over. Mass-Market Compounding Should Be, Too
The market for copycat versions remains substantial. By one estimate, roughly 1.5 million Americans take compounded GLP-1s. That's cause for concern.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The market for copycat versions remains substantial. By one estimate, roughly 1.5 million Americans take compounded GLP-1s. That's cause for concern.
Join the argument
House rules →Comments load as you scroll.